Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krahn

Showing results (791-800 of 1,751) with videos related to

Pageof 176
Sort By:
JAMA|September 14, 1994
Screening for prostate cancer. A decision analytic viewM D Krahn, J E Mahoney, M H Eckman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 1, 1996
Examining serotonin function: a modified technique for rapid tryptophan depletionL E Krahn, P Y Lu, G Klee, et al.
Veterinary Anaesthesia and Analgesia|March 18, 2017
Intravenous 15% isoflurane lipid nanoemulsion for general anesthesia in dogsClaudio C Natalini, Carolina L Krahn, Priscila B S Serpa, et al.
The American Journal of Medicine|July 18, 2003
A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncopeSoori Sivakumaran, Andrew D Krahn, George J Klein, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 18, 2005
Feasibility of his bundle pacing as an alternative pacing site: measurement of his refractorinessLorne J Gula, Geoffrey M Trim, Andrew D Krahn, et al.
Diseases of the Colon and Rectum|January 20, 2005
Azathioprine or ileocolic resection for steroid-dependent terminal ileal Crohn's disease? A Markov analysisErin D Kennedy, David R Urbach, Murray D Krahn, et al.
Cancer|February 21, 2008
Is there an optimal comorbidity index for prostate cancer?Shabbir M H Alibhai, Marc Leach, George A Tomlinson, et al.
Journal of Cancer Survivorship : Research and Practice|August 27, 2013
Patient time and out-of-pocket costs for long-term prostate cancer survivors in Ontario, CanadaClaire de Oliveira, Karen E Bremner, Andy Ni, et al.
Pharmacoeconomics|June 21, 2021
Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT)Michael J Zoratti, Kelvin K W Chan, Don Husereau, et al.
BMJ Open|December 7, 2018
Non-standard treatment for uncomplicated <i>Chlamydia trachomatis</i> urogenital infections: a systematic reviewJessica Krahn, Aaron Louette, Vera Caine, et al.
Pageof 176

Showing results (791-800 of 1,751) with videos related to

Sort By:
Pageof 176
JAMA|September 14, 1994
Screening for prostate cancer. A decision analytic viewM D Krahn, J E Mahoney, M H Eckman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 1, 1996
Examining serotonin function: a modified technique for rapid tryptophan depletionL E Krahn, P Y Lu, G Klee, et al.
Veterinary Anaesthesia and Analgesia|March 18, 2017
Intravenous 15% isoflurane lipid nanoemulsion for general anesthesia in dogsClaudio C Natalini, Carolina L Krahn, Priscila B S Serpa, et al.
The American Journal of Medicine|July 18, 2003
A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncopeSoori Sivakumaran, Andrew D Krahn, George J Klein, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 18, 2005
Feasibility of his bundle pacing as an alternative pacing site: measurement of his refractorinessLorne J Gula, Geoffrey M Trim, Andrew D Krahn, et al.
Diseases of the Colon and Rectum|January 20, 2005
Azathioprine or ileocolic resection for steroid-dependent terminal ileal Crohn's disease? A Markov analysisErin D Kennedy, David R Urbach, Murray D Krahn, et al.
Cancer|February 21, 2008
Is there an optimal comorbidity index for prostate cancer?Shabbir M H Alibhai, Marc Leach, George A Tomlinson, et al.
Journal of Cancer Survivorship : Research and Practice|August 27, 2013
Patient time and out-of-pocket costs for long-term prostate cancer survivors in Ontario, CanadaClaire de Oliveira, Karen E Bremner, Andy Ni, et al.
Pharmacoeconomics|June 21, 2021
Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT)Michael J Zoratti, Kelvin K W Chan, Don Husereau, et al.
BMJ Open|December 7, 2018
Non-standard treatment for uncomplicated <i>Chlamydia trachomatis</i> urogenital infections: a systematic reviewJessica Krahn, Aaron Louette, Vera Caine, et al.
Pageof 176